Increased expression of senescence-associated cell cycle inhibitor p16/INK4a in deteriorating renal transplants and diseased native kidney

American Journal of Transplantation

Volumn 5, Issue 6, 2005, Pages 1375-1382

  Melk, Anette ^a,b   Schmidt, Bernhard M W ^a   Vongwiwatana, Attapong ^a   Rayner, David C ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Aging; Cell cycle; Interstitial fibrosis; Kidney; Senescence; Transplantation; Tubular atrophy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN P16INK4A; TACROLIMUS;

ADOLESCENT; ADULT; AGING; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MALE; NEPHRON; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SOMATIC CELL;

ADULT; AGED; AGING; CHRONIC DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 20544432681     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00846.x     Document Type: Article

References (33)

1. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998; 66: 1736-1740.
2. Massy ZA, Guijarro C, Kasiske BL. Clinical predictors of chronic renal allograft rejection. Kidney Int Suppl 1995; 52: S85-S88.
3. Weir MR, Ward MT, Blahut SA et al. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. Kidney Int 2001; 59: 1567-1573.
4. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-638.
5. Moreso F, Lopez M, Vallejos A et al. Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 2001; 1: 82-88.
6. Kasiske BL, Heim-Duthoy KL, Tortorice KL, Rao KV. The variable nature of chronic declines in renal allograft function. Transplantation 1991; 51: 330-334.
7. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int 2002; 62: 1848-1854.
8. Halloran PF. Call for revolution: a new approach to describing allograft deterioration. Am J Transplant 2002; 2: 195-200.
9. Ponticelli C. Progression of renal damage in chronic rejection. Kidney Int 2000; 57(Suppl. 75): S62-S70.
10. Nishi T, Bond C, Jr., Brown G, Solez K, Heptinstall RH. Amorphometric study of arterial intimai thickening in kidneys of dialyzed patients. Am J Pathol 1979; 95: 597-610.
11. Racusen LC, Solez K, Colvin R. Fibrosis and atrophy in the renal allograft: interim report and new directions. Am J Transplant 2002; 2: 203-206.
12. Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and c4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004; 4: 124-129.
13. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181.
14. Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol 2002; 20: 682-688.
15. Sherr CJ, DePinho RA. Cellular senescence: mitotic clock or culture shock? Cell 2000; 102: 407-410.
16. Beausejour CM, Krtolica A, Galimi F et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22: 4212-4222.
17. Carnero A, Hudson JD, Price CM, Beach DH. p16(INK4A) and p19(ARF) act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000; 2: 148-155.
18. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993-1000.
19. Melk A, Ramassar V, Helms LMH et al. Telomere shortening in kidneys with age. J Am Soc Nephrol 2000; 11: 444-453.
20. Melk A, Kittikowit W, Sandhu I et al. Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int 2003; 63: 2134-2143.
21. Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 2004; 65: 510-520.
22. Ferlicot S, Durrbach A, BA N, Desvaux D, Bedossa P, Paradis V. The role of replicative senescence in chronic allograft nephropathy. Human Pathology 2003; 34: 924-928.
23. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
24. INK4a is induced in acute rejection: evidence that rejection induces epithelial cell senescence. Am J Transplant 2003; 3(Suppl. 5): 542 (Abstract 1521).
25. Melk A, Schmidt BMW, Urmson J, Solez K, Halloran PF. Does donor age affect immunogenicity or tissue fragility? Evidence that old kidneys develop equivalent inflammation but more tubulitis and tubular atrophy. Am J Transplant 2003; 3(Suppl. 5): 542 (Abstract 1520).
26. Joosten SA, Van HV, Nolan CE et al. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol 2003; 162: 1305-1312.
27. Kasiske BL, Kalil RSN, Lee HS, Rao V. Histopathologic findings associated with a chronic, progressive decline in renal allograft function. Kidney Int 1991; 40: 514-524.
28. Gjertson DW. Determinants of long term survival of adult kidney transplants. In: P Terasaki, JM Cecka, eds. Clinical Transplants 1999. Los Angeles(CA): UCLA Immunogenetics Center, 2000: 341-352.
29. Cicciarelli J, Iwaki Y, Mendenz R. The influence of donor age on kidney graft survival in the 1990s. In: JM Cecka, PI Terasaki, eds. Clinical Transplants. Los Angeles(CA): UCLA Tissue Typing Laboratory, 1999: 335-340.
30. Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000; 11: 565-573.
31. Bricker NS, Morrin PA, Kime SW Jr., The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis". J Am Soc Nephrol 1997; 8: 1470-1476.
32. Rastaldi MP, Ferrario F, Giardino L et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137-146.
33. Emig R, Magener A, Ehemann V et al. Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer 1998; 78: 1661-1668.